UK Medicines Information
The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use in humans ‘specials’
Information type:
Guidance
Source:
Medicines and Healthcare products Regulatory Agency
Specialities:
Anaesthesia and pain | Neurological disorders
Summary
In this document the MHRA provides specific guidance in relation to unlicensed cannabis-based products for medicinal use in humans following its rescheduling to allow its use for medical purposes.
UKMi comment
NHS England has issued guidance to clinicians on cannabis-based products for medicinal use.
Related links:
NHS England guidance